DUBLIN (AP) _ Amarin Corp. PLC (AMRN) on Wednesday reported a loss of $24.1 million in its first quarter.
The Dublin-based company said it had a loss of 8 cents per share. Losses, adjusted for stock option expense, were 7 cents per share.
The results met Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was also for a loss of 7 cents per share.
The biopharmaceutical company posted revenue of $43.9 million in the period.
The company's shares closed at $2.80. A year ago, they were trading at $3.18.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRN at https://www.zacks.com/ap/AMRN